度那雄胺治疗效果怎么样？

Dunasteride (Avodart) has been clinically used as a 5α reductase inhibitor to block this link to effectively treat prostatic hyperplasia (BPH). Dunasteride (Avodart) is used to reduce the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of benign prostatic hyperplasia. Dunasteride (Avodart) is a new dual inhibitor of 5α reductase. Dunasteride (Avodart) inhibits both 5α reductase 1 and 5α reductase 2. How is the treatment effect?

At 0.5 mg per day, the dihydrotestosterone (DHT)-lowering effect of Dunasteride (Avodart) reaches its peak after 1 to 2 weeks of treatment, and plasma dihydrotestosterone (DHT) can be reduced by 85% to 90%. A patient with prostate enlargement took 5 mg of Dunasteride (Avodart) every day, and his level of hydrotestosterone (DHT) was significantly reduced in 12 weeks.

To observe the clinical efficacy of the 5α-reductase inhibitor dunasteride (Avodart) in the treatment of benign prostatic hyperplasia (BPH). Methods: 56 patients were randomly divided into a treatment group and a control group. The treatment group took Avodart 0.5 mg, and the control group took Finasteride 5 mg. Both groups took it once/d, and the course of treatment was 6 months.

Results: After treatment, compared with before treatment, the patients' quality of life scores, residual urine volume, maximum urinary flow rate, prostate volume and other indicators were significantly improved in the two groups. There was no statistically significant difference in the total effective rate between the two groups. Conclusion: Dunasteride (Avodart) is safe and effective in the treatment of prostatic hyperplasia (BPH), and its clinical efficacy is certain. Patients should strictly follow the doctor's instructions during treatment with Dunasteride (Avodart) and should not increase or decrease the dosage of Dunasteride (Avodart) without authorization to avoid adverse reactions caused by increased or decreased dosage.

The above is an introduction to Dunasteride (Avodart). If patients want to know more about Dunasteride drug information, they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: